The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Abstract Background There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer’s disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery (EMI...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Isabelle Bos, Stephanie Vos, Rik Vandenberghe, Philip Scheltens, Sebastiaan Engelborghs, Giovanni Frisoni, José Luis Molinuevo, Anders Wallin, Alberto Lleó, Julius Popp, Pablo Martinez-Lage, Alison Baird, Richard Dobson, Cristina Legido-Quigley, Kristel Sleegers, Christine Van Broeckhoven, Lars Bertram, Mara ten Kate, Frederik Barkhof, Henrik Zetterberg, Simon Lovestone, Johannes Streffer, Pieter Jelle Visser
Formaat: Artikel
Taal:English
Gepubliceerd in: BMC 2018-07-01
Reeks:Alzheimer’s Research & Therapy
Onderwerpen:
Alzheimer’s disease
Biomarkers
Multimodal
Proteomics
Genomics
Metabolomics
Online toegang:http://link.springer.com/article/10.1186/s13195-018-0396-5

Internet

http://link.springer.com/article/10.1186/s13195-018-0396-5

Gelijkaardige items